Spago Nanomedical AB (SPAGO) - Total Liabilities

Latest as of December 2025: Skr5.94 Million SEK ≈ $638.92K USD

Based on the latest financial reports, Spago Nanomedical AB (SPAGO) has total liabilities worth Skr5.94 Million SEK (≈ $638.92K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Spago Nanomedical AB (SPAGO) cash flow conversion to assess how effectively this company generates cash.

Spago Nanomedical AB - Total Liabilities Trend (2011–2025)

This chart illustrates how Spago Nanomedical AB's total liabilities have evolved over time, based on quarterly financial data. Check Spago Nanomedical AB liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Spago Nanomedical AB Competitors by Total Liabilities

The table below lists competitors of Spago Nanomedical AB ranked by their total liabilities.

Company	Country	Total Liabilities
GENINCODE PLC LS -01 F:9PL	Germany	€1.56 Million
National Plastic Co Ltd Preferred KO:004255	Korea	₩168.34 Billion
Truscreen Group Ltd AU:TRU	Australia	AU$951.80K
Sky Quarry Inc NASDAQ:SKYQ	USA	$15.39 Million
Ho Hup Construction Company KLSE:5169	Malaysia	RM293.73 Million
Noble Mineral Exploration Inc V:NOB	Canada	CA$612.63K

Liability Composition Analysis (2011–2025)

This chart breaks down Spago Nanomedical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Spago Nanomedical AB market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Spago Nanomedical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Spago Nanomedical AB (2011–2025)

The table below shows the annual total liabilities of Spago Nanomedical AB from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr5.94 Million ≈ $638.92K	-6.47%
2024-12-31	Skr6.35 Million ≈ $683.15K	-45.59%
2023-12-31	Skr11.67 Million ≈ $1.26 Million	+32.64%
2022-12-31	Skr8.80 Million ≈ $946.70K	+29.14%
2021-12-31	Skr6.81 Million ≈ $733.08K	+116.53%
2020-12-31	Skr3.15 Million ≈ $338.56K	+8.15%
2019-12-31	Skr2.91 Million ≈ $313.05K	-29.00%
2018-12-31	Skr4.10 Million ≈ $440.90K	+7.50%
2017-12-31	Skr3.81 Million ≈ $410.12K	-53.63%
2016-12-31	Skr8.22 Million ≈ $884.50K	-11.90%
2015-12-31	Skr9.33 Million ≈ $1.00 Million	-52.23%
2014-12-31	Skr19.53 Million ≈ $2.10 Million	-0.81%
2013-12-31	Skr19.69 Million ≈ $2.12 Million	+73.35%
2012-12-31	Skr11.36 Million ≈ $1.22 Million	-8.57%
2011-12-31	Skr12.42 Million ≈ $1.34 Million	--

About Spago Nanomedical AB

ST:SPAGO Sweden Biotechnology

Market Cap

$8.47 Million

Skr78.73 Million SEK

Market Cap Rank

#27272 Global

#600 in Sweden

Share Price

Skr0.12

Change (1 day)

+5.78%

52-Week Range

Skr0.09 - Skr0.40

All Time High

Skr19.04